Volume 92, Issue 7 pp. 1458-1460
Valvular and Structural Heart Diseases

Supra-annular valve strategy for an early degenerated transcatheter balloon-expandable heart valve

Norihiko Kamioka MD

Norihiko Kamioka MD

Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia

Search for more papers by this author
Hope Caughron BA

Hope Caughron BA

Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia

Search for more papers by this author
Frank Corrigan MD

Frank Corrigan MD

Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia

Search for more papers by this author
Peter Block MD

Peter Block MD

Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia

Search for more papers by this author
Vasilis Babaliaros MD

Corresponding Author

Vasilis Babaliaros MD

Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia

Correspondence Vasilis Babaliaros, MD, Emory University Hospital F606, 1364 Clifton Road, Atlanta, GA 30322. Email: [email protected]Search for more papers by this author
First published: 23 January 2018
Citations: 1

Abstract

Currently, there are no recommendations regarding the selection of valve type for a transcatheter heart valve (THV)-in-THV procedure. A supra-annular valve design may be superior in that it results in a larger effective orifice area and may have a lower chance of valve thrombosis after THV-in-THV. In this report, we describe the use of a supra-annular valve strategy for an early degenerated THV.

CONFLICT OF INTEREST

Vasilis Babaliaros MD, FACC is a consultant for Abbott Vascular and Edwards Lifesciences. The other authors have nothing to disclose.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.